Opus Capital Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,936
| Closed | -$362K | – | 182 |
|
|
2019
Q1 | $362K | Hold |
6,936
| – | – | 0.1% | 160 |
|
|
2018
Q4 | $331K | Hold |
6,936
| – | – | 0.07% | 171 |
|
|
2018
Q3 | $348K | Sell |
6,936
-928
| -12% | -$46.6K | 0.08% | 183 |
|
|
2018
Q2 | $396K | Hold |
7,864
| – | – | 0.1% | 151 |
|
|
2018
Q1 | $384K | Buy |
+7,864
| New | +$384K | 0.1% | 157 |
|
|
2017
Q4 | – | Sell |
-7,856
| Closed | -$399K | – | 247 |
|
|
2017
Q3 | $399K | Buy |
7,856
+1,144
| +17% | +$58.1K | 0.09% | 157 |
|
|
2017
Q2 | $362K | Hold |
6,712
| – | – | 0.07% | 145 |
|
|
2017
Q1 | $354K | Hold |
6,712
| – | – | 0.05% | 182 |
|
|
2016
Q4 | $323K | Hold |
6,712
| – | – | 0.05% | 184 |
|
|
2016
Q3 | $362K | Sell |
6,712
-78
| -1% | -$4.21K | 0.07% | 145 |
|
|
2016
Q2 | $368K | Hold |
6,790
| – | – | 0.08% | 144 |
|
|
2016
Q1 | $344K | Buy |
6,790
+78
| +1% | +$3.95K | 0.08% | 153 |
|
|
2015
Q4 | $339K | Hold |
6,712
| – | – | 0.06% | 204 |
|
|
2015
Q3 | $323K | Hold |
6,712
| – | – | 0.05% | 201 |
|
|
2015
Q2 | $349K | Buy |
6,712
+736
| +12% | +$38.3K | 0.05% | 189 |
|
|
2015
Q1 | $345K | Hold |
5,976
| – | – | 0.05% | 192 |
|
|
2014
Q4 | $319K | Hold |
5,976
| – | – | 0.05% | 198 |
|
|
2014
Q3 | $343K | Sell |
5,976
-9,188
| -61% | -$527K | 0.05% | 200 |
|
|
2014
Q2 | $1.01M | Buy |
15,164
+1,640
| +12% | +$110K | 0.07% | 118 |
|
|
2014
Q1 | $903K | Hold |
13,524
| – | – | 0.06% | 113 |
|
|
2013
Q4 | $903K | Buy |
+13,524
| New | +$903K | 0.05% | 114 |
|
|
2013
Q3 | – | Sell |
-7,548
| Closed | -$471K | – | 138 |
|
|
2013
Q2 | $471K | Buy |
+7,548
| New | +$471K | 0.03% | 108 |
|